Outcome Evaluation After Fertility Preservation

January 6, 2026 updated by: Chung Pui Wah Jacqueline, Chinese University of Hong Kong
It is important to evaluate outcomes after different fertility preservation strategies. Therefore, this study aims to assess the outcomes after different fertility preservation strategies and identify any factors that may affect their reproductive outcome.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

All patients who have undergone or will seek fertility preservation services in PWH will be invited to participate. For those patients who have undergone fertility preservation services in PWH, when they come back to use their frozen gametes or embryos, they will also be invited to participate.

Medical record assessment When patients come for fertility preservation consultation in PWH, they will be invited to participate. The medical notes of these patients undergoing fertility preservation services will be reviewed. The baseline characteristics including the socio-demographic background, past medical history, details of the surgical procedures, and the subsequent reproductive outcome, will be obtained by reviewing their hospital record. The participants will not be required to take any extra procedures.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All patients who have undergone or will seek for fertility preservation services in PWH will be invited to participate.

Description

Inclusion Criteria:

  • Patients aged from 0-50 years old
  • Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
  • Patients seek for fertility preservation services

Exclusion Criteria:

-Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To determine any factors that may affect the success rate of different fertility preservation methods.
Time Frame: 10 years
The medical notes of these patients undergoing fertility preservation services will be reviewed. The baseline characteristics including the socio-demographic background will be obtained by reviewing their hospital record.
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To assess the pregnancy rate after different fertility preservation methods.
Time Frame: 10 years
The medical notes of these patients undergoing fertility preservation services will be reviewed. The subsequent reproductive outcome will be obtained by reviewing their hospital record.
10 years
To report on the frequency of surgical complications
Time Frame: 10 years
The medical notes of these patients undergoing fertility preservation services will be reviewed. The details of the surgical procedures will be obtained by reviewing their hospital record.
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chinese University of Hong Kong

Investigators

  • Principal Investigator: Jacqueline CHUNG, MBBS, Chinese University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 21, 2023

Primary Completion (Estimated)

October 1, 2033

Study Completion (Estimated)

October 1, 2035

Study Registration Dates

First Submitted

September 12, 2023

First Submitted That Met QC Criteria

September 12, 2023

First Posted (Actual)

September 21, 2023

Study Record Updates

Last Update Posted (Actual)

January 8, 2026

Last Update Submitted That Met QC Criteria

January 6, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023.346

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on This is an observational cohort study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe